Health

‘We have to better support women’: MP leading the fight on menopause

Carolyn Harris remembers hearing her mother and aunties talking about “the change” menopause. She was told to make a cup of tea and sent out of the room. “I was 36!” hoots the Labour MP for Swansea East. “Later I said to my mum, ‘What did you think you were protecting me from? It was always going to happen to me too’.”

Harris is now at the vanguard of a movement determined to smash the remnants of that taboo, pushing a private member’s bill to turn up the volume on a debate about the menopause that is growing louder by the day.

As an increasing number of countries, businesses and individuals mark World Menopause Day on Monday, Harris says she is ready to shame whoever stands in the way of progress.

“You don’t get change unless you ask for it, and you demand it, or you put people in a position where they’re going to look like right bastards if they don’t do something about it,” she says with typical candour. “I want to be in a position where the government can’t say no and where companies won’t say no.”

Harris will lead a small army of supporters to Parliament Square in London before her bill, which is due to be heard on the 29 October, to demand free prescriptions for hormone replacement therapy in England – already available in Scotland and Wales. The government is said to be “interested” in the bill, with Harris adding that she has cross-party support from dozens of MPs including the Tory grandees Bernard and Anne Jenkin, alongside Caroline Nokes and Tim Loughton, as well as Jess Phillips, Diane Abbott and Sarah Champion in the Labour ranks.

“In the last two years the narrative has completely changed,” says Harris, who adds that since the private members bill was announced she’s had calls from countries from Canada and the US, to Australia and Japan.

“People are waking up to the fact that we have to find a better way of supporting women through the menopause,” she says. “Women are enhanced coming through this process, but only if they get the support they need.”

The evidence suggests they all too often don’t. There are more than 13 million currently experiencing menopause or perimenopause in the UK. Menopause campaigners argue that medical sexism and a lack of training means many women are left to suffer the symptoms of menopause – which can include depression, anxiety, insomnia and brain fog as well as hot flushes.

The UK could be losing 14m work days a year related to the menopause, according to recent research. One in four women who experience menopausal symptoms – many at the top of their career – consider leaving their job.

Many more businesses are joining the menopause revolution, says Harris – pointing to companies such as Cult Beauty which has introduced comprehensive policies around miscarriage, IVF, pregnancy and the menopause and hosted Harris at an event last week. Alexia Inge, the company’s co-chief executive, says that with a 78% female workforce it was a moral and business imperative. “As a nation we’re actually losing people from the workforce at a time when we need people to work later in life,” she says. “Even if you take the really important social care elements away, we need to support people to go through this.”

But it’s not enough to have a policy, says Harris. “This can’t be a box-ticking exercise, companies and the government really have to genuinely want to help these workers.”

Harris’s own experience with the menopause was brutal. Twenty years after losing her eight-year-old son in a road traffic accident she blamed herself for not processing her grief when she was hit by a deep depression. “It took me six years, having conversations with women, for me to realise I was going through the menopause,” she says.

Now she wants to use her voice in parliament to speak up for those who she says are often just too tired to fight. “There’s a hell of a lot of women my age, working in supermarkets in shops and they are exhausted,” she says. “A lot of those women are going through the menopause but they are not being treated, because in 2021 there is still not enough understanding about a condition that affects 51% of the population.”

With Harris leading the charge, with an army of women alongside her, that may be starting to change. “I don’t throw stones – I’ll work with anyone to get this done,” she says. “But if I’ve got to throw boulders to get what I want, I will.”

Health

WHO appoints Ihekweazu as ED Health Emergencies Programme

Nigerian epidemiologist, Dr. Chikwe Ihekweazu has been appointed as the Executive Director of the World Health Organisation’s (WHO) Health Emergencies Programme. This appointment marks a significant milestone, placing a Nigerian at the helm of WHO’s largest department responsible for coordinating global responses to health emergencies.

Prior to this role, Ihekweazu served as WHO’s Assistant Director-General for Health Emergency Intelligence and Surveillance Systems. He is also widely recognised for his transformative leadership as the founding Director-General of the Nigeria Centre for Disease Control (NCDC), where he led the agency from 2016 to 2021, establishing it as one of Africa’s leading public health institutions.

In February 2025, Ihekweazu was appointed Acting Regional Director for WHO Africa, succeeding Dr. Matshidiso Moeti. His tenure during this transition period received commendations for his leadership until the nomination of Professor Mohamed Yakub Janabi as the next Regional Director.

Ihekweazu’s appointment comes at a critical time as the world faces numerous health challenges, including emerging infectious diseases, the impacts of climate change, and strained health financing. His extensive background in public health and epidemiology is expected to bolster WHO’s capacity to respond effectively to global health emergencies.

The Federal Ministry of Health and Social Welfare celebrated his appointment, describing it as a proud moment for Nigeria. Coordinating Minister Prof. Muhammad Ali Pate hailed Ihekweazu as ‘the right choice at the right time’, praising his bold and compassionate leadership as crucial for navigating the complexities of the global health landscape.

Ihekweazu succeeds Dr. Mike Ryan, who led the Health Emergencies Programme through critical events, including the COVID-19 pandemic. In his new role, Ihekweazu will oversee WHO’s preparedness, response, and mitigation efforts for global health emergencies, ensuring that the organization remains agile and effective in safeguarding public health.

His appointment is part of a broader leadership restructuring within WHO, aimed at enhancing its operational efficiency and responsiveness to global health challenges.

Ihekweazu’s career spans senior roles at the South African National Institute for Communicable Diseases, the UK’s Health Protection Agency, and Germany’s Robert Koch Institute. He holds a Master of Public Health from Heinrich Heine University in Düsseldorf, Germany, and is an alumnus of the European Programme for Intervention Epidemiology Training.

His leadership is anticipated to bring renewed focus to strengthening health systems, improving surveillance, and fostering international collaboration to address current and emerging health threats.

Ihekweazu’s appointment not only underscores his exceptional contributions to global health but also highlights Africa’s growing influence in shaping international health policy and governance.

Health

Bayelsa records 98% immunisation coverage

Bayelsa has recorded a 98 per cent coverage in the first round of the 2025 National Immunisation Plus Days (NIPDs) programme conducted from the May 3 to May 6.

Mr Lawrence Ewhrudjakpo, deputy governor of the state, disclosed this during a meeting of the state’s taskforce on immunisation in Yenagoa on Wednesday.

He said that the government’s ultimate target was to achieve 100 per cent coverage in subsequent immunisation campaigns.

Ewhrudjakpo lauded the WHO, UNICEF, the Ministry of Health and other critical stakeholders for the feat achieved so far.

He, however, urged the partners not to rest on their oars as much still have to be done to achieve its target of 100 per cent immunization coverage.

He underscored the need for early preparations ahead of the second round of 2025 NIPDs scheduled for July.

The deputy governor assured the partners that funds for the programme would be released not later than two weeks to its commencement.

He directed all council chairmen to flag-off the second round of the 2025 NIPDs programme at any community other than their respective local government headquarters.

The deputy governor urged the chairmen to meet with the traditional rulers, school proprietors, and religious leaders in their areas to sensitise them on the importance of immunisation.

He also called parents, schools and churches to allow children to participate in the immunisation programme.

”The state government is serious about enforcing its public health law and executive order on compulsory immunisation.

“We have taken our immunisation coverage up to 98 per cent. But we want to take it to 100 per cent this time around, and that is why we have convened this meeting.

“We are also going to make an upward review of the logistics to reflect the present economic realities in the country,” he said.

Presentations by Dr Marcus Oluwadare of the WHO, and Dr Gbanaibulou Orukari, Director of Disease Control, Bayelsa State Primary Healthcare Board, revealed that area councils scored high percentage in the coverage.

They, however, identified poor workload rationalisation, data falsification and lack of commitment on the part of some personnel.

According to Oluwadare, we commend the Deputy Governor of the state for flagging off the NIPDs and chairing all the state ERMs in spite of his tight schedule.

“Bayelsa State was the only state to have full complements of her stakeholders in attendance during the April NIPDs in the whole of Nigeria,” he said.

Health

NCDC records 832 Lassa fever, Mpox cases, 135 deaths

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed the country has recorded 832 confirmed cases of Lassa fever and Mpox.

Speaking during a press briefing on Friday in Abuja, the agency’s Director General, Dr. Jide Idris, revealed that 132 fatalities were recorded from Lassa fever and three from Mpox.

While acknowledging a recent decline in Lassa fever infections during epidemiological week 16 (ending April 20, 2025), he warned that the overall risk remains high, particularly in endemic regions.

“Cumulatively, as of week 16, Nigeria has reported 4,253 suspected cases of Lassa fever, 696 confirmed cases, and 132 deaths, resulting in a case fatality rate of 19.0 percent,” he stated.

Dr. Idris attributed recent improvements to intensified surveillance, treatment efforts, and enhanced community engagement. He emphasized, however, the continued need for vigilance and collaboration to sustain progress.

Regarding Mpox, the NCDC boss disclosed that three deaths have been recorded in 2025—two in Abia and Ebonyi States in week 10, and one recently in Rivers State involving a patient co-infected with HIV and tuberculosis. As of week 16, 723 suspected cases and 136 laboratory-confirmed cases of Mpox have been reported across 35 states and the Federal Capital Territory (FCT). The national case fatality rate currently stands at 2.2 per cent.

“The epidemic curve reveals multiple peaks in Mpox cases, indicating ongoing transmission. While most states have reported suspected cases, confirmed infections are heavily concentrated in Nigeria’s southern and central regions,” Dr. Idris noted.

To address these outbreaks, the NCDC has activated its Emergency Operations Centre (EOC), deployed National Rapid Response Teams to affected states, and prepositioned essential medical supplies, including personal protective equipment and laboratory consumables. Five additional Mpox diagnostic laboratories have also been optimized in Bauchi, Kano, Cross River, Rivers, and Enugu States.

“Healthcare workers are undergoing specialized training in infection prevention, case management, and cerebrospinal meningitis (CSM) care. Community outreach is being reinforced through public awareness campaigns, media engagement, and targeted health communication strategies,” he added.

On cerebrospinal meningitis, Dr. Idris reported a consistent decline in new cases and fatalities over the last three weeks.

He attributed the improvement to effective vaccination, early treatment, and adaptive surveillance strategies tailored to real-time data.

“Although the situation remains serious, strong national and state-level coordination is showing positive results. The response will continue until full containment is achieved and states take full ownership of the CSM Incident Action Plan,” he said.

Dr. Idris also expressed concern about the rising Mpox trend since its reemergence in 2017, with significant spikes recorded between 2022 and 2024, positioning Nigeria among the most affected countries globally. He warned that underreporting and delayed data entry remain challenges that need urgent resolution to ensure accurate and timely outbreak response.

A national mortality review for the recent Mpox deaths is being planned to further assess response effectiveness and identify areas for improvement.

The NCDC reaffirmed its commitment to safeguarding public health through timely surveillance, transparent reporting, and coordinated national response mechanisms aimed at reducing disease burden and preventing future outbreaks.